Navigation Links
Bio-IT World Announces the Winners of its 2009 Best Practices Awards Program

Bio-IT World magazine today announced the winners of its fifth Best Practices Awards program. Grand Prize winners within eight life sciences awards categories include Abbott Laboratories, Amgen, the Broad Institute of MIT and Harvard, Genedata, Genentech, GlaxoSmithKline, Merck & Co., the National Center for Genome Resources, Vanderbilt University, and Wyeth Research.

Needham, Mass (PRWEB) April 29, 2009 -- Bio-IT World magazine today announced the winners of its fifth Best Practices Awards program. Grand Prize winners within eight life sciences awards categories include Abbott Laboratories, Amgen, the Broad Institute of MIT and Harvard, Genedata, Genentech, GlaxoSmithKline, Merck & Co., the National Center for Genome Resources, Vanderbilt University, and Wyeth Research.

Established in 2003, Bio-IT World's Best Practices Awards Program recognizes these organizations for their outstanding innovations and excellence in the use of technologies, practices, and novel business strategies that will advance drug discovery, development, biomedical research, and clinical trials. The competition's first Judges' Prize goes to the Children's Hospital of Philadelphia for their Pediatric Knowledgebase and the recipient of the Editors' Choice Award is AstraZeneca, nominated by BioWisdom, for their Safety Intelligence Program.

Bio-IT World's Best Practices Awards ceremony was held last night at the World Trade Center in Boston, Mass., co-located with CHI's Seventh Annual Bio-IT World Conference & Expo. Key industry leaders attended the ceremony, which featured a keynote speech by Michael Cariaso, senior scientific consultant, BioTeam, on "Technology Without Borders: Teaching Programming and Internet Skills in Rural Southeast Asia."

Phillips Kuhl, co-founder and president of Cambridge Healthtech Institute (CHI), started the evening with welcoming comments and introduced Kevin Davies, Ph.D., editor-in-chief of Bio-IT World, the flagship publication of CHI, to initiate the presentation of awards.

"These annual awards spotlight examples of the most outstanding innovations, technologies, and practices in the fields of biomedical research, drug development, and clinical research--spotlighting the tools and strategies that can make a difference in the conduct of basic and clinical research, speeding the drug discovery pipeline, and changing the way we generate, share and analyze data and knowledge," said Kevin Davies, editor in chief of Bio-IT World.

"We especially thank our volunteer judges for their time, expertise, and enthusiasm in reviewing and debating the merits of the record number of entries received this year. And we congratulate the distinguished winners of the 2009 Bio-IT World Best Practices Awards, and hope these outstanding examples of technology innovation and collaboration will drive future discoveries across basic, pharma, and clinical research."

A peer-review panel of 14 expert judges reviewed a record 72 detailed submissions from organizations ranging from large pharmaceutical and biotechnology companies, academic institutions, to niche service providers, detailing best practices in one of eight categories. Allison Proffitt, managing editor of Bio-IT World; Gerard Sample, senior product marketing manager, BlueArc; Grant Stephen, CEO Tessella; Phillips Kuhl; and Kevin Davies presented the Grand Prize trophies to the following organizations within these categories:

  • Basic Research: National Center for Genome Resources.
NCGR's Schizophrenia Genome Project

  • Clinical Trials Management: Genentech
(Nominated by ePharmaSolutions): The Clinical Trial Portal

  • Clinical Trials Design: Wyeth Research
(Nominated by Tessella): Design of adaptive clinical trials using Adaptive Design Explorer

  • Drug Discovery & Development: Amgen and Genedata
Amgen Lead Discovery Informatics

  • IT & Informatics: The Broad Institute of MIT and Harvard

  • Knowledge Management: Vanderbilt University
(Nominated by ActiveHealth Management): A computerized, clinically intelligent system to deliver clinical alerts to physicians and their patients improves care and lowers health care costs.

  • Knowledge Management, Pharma: Abbott Laboratories and Merck & Co.
(Nominated by Accelrys): Biological Knowledge Management: Registration, Association, and Sharing

  • Translational and Personalized Medicine: GlaxoSmithKline
(Nominated by ProSanos Corporation): SÆfty Works: Leveraging Observational data to explore the effects of medicines

  • Judges' Prize: Children's Hospital of Philadelphia
Pediatric Knowledgebase

  • Editors' Choice Award: AstraZeneca
(Nominated by BioWisdom): Safety Intelligence Program.

The following entries received honorable mentions:

  • AstraZeneca nominated by Medidata Solutions
  • Pathworks Diagnostics nominated by Univa UD
  • Genentech nominated by Dolcera
  • AstraZeneca nominated by Thermo Fisher Scientific
  • CEA (Commissariat à l'Energie Atomique) nominated by Bio-Modeling Systems

Criteria and Judging
Awards finalists and winners were selected for their innovative utilization of bio-IT, including life science equipment, informatics and information technology, on a project or organizational level to achieve significantly improved results (i.e. improvements in productivity or conceptual breakthroughs in scientific understanding or process methodology). The peer review judges applied several criteria to make their decisions, such as innovation, significance, and industry impact. Entries were accepted from R&D and scientific facilities and labs in pharmaceutical companies, biotech companies, academia, government, medical or related institutions and organizations, as well as public and private research labs. For information on Bio-IT World's 2009 Best Practices Awards, please email The July/August issue of Bio-IT World will feature editorial on Best Practices, highlighting award winners, profiling entrants, event coverage and the enabling technologies used by the many companies.

The 2009 Best Practices Awards were organized by Bio-IT World editors, including Managing Editor Allison Byrum Proffitt, Editor-in- Chief Kevin Davies, and key marketing & operations staff members of Cambridge Healthtech Media Group, a division of CHI. Joining the editors in judging the entries was a distinguished panel of experts, including:

  • Stephen Fogelson, Devolotron
  • Stan Kachnowski, Health Information and Technology Lab
  • Jerry Schindler, Merck
  • Sandy Aronson, Harvard Medical School
  • Ernie Bush, Cambridge Healthtech Associates
  • Joseph Cerro, Consultant
  • Al Doig, CHI Insight Pharma Reports
  • Bill Van Etten, BioTeam
  • Noemi Greyzdorf, IDC
  • Jim Kremidas, Quintiles
  • Alan Louie, Health Industry Insights/IDC
  • Eric Neumann, Clinical Semantics Group
  • Deepak Thakkar, SGI
  • Phillips Kuhl, Cambridge Healthtech Institute

Sponsors generously underwriting the 2009 Best Practices Awards are Tessella, BlueArc Corporation, and Lilly Singapore Centre for Drug Discovery.

The winners will be profiled in the July/August issue of Bio-IT World. The 2010 Bio-IT World Best Practices competition will begin soliciting entries in October 2009.

About Bio-IT World
Bio-IT World (, the flagship publication of Cambridge Healthtech Institute (CHI), is the leading source of news on technology and strategic innovation in drug discovery, development, and clinical trials. Bio-IT World explores the tools and results of predictive biology as the industry adapts to the new world of personalized medicine. Bio-IT World has won 34 national and regional awards, more than any other magazine covering the life sciences industry. CHI offers a suite of published resources through a new division--Cambridge Healthtech Media Group--that includes Bio-IT World magazine, several topic-specific eNewsletters, white papers, webcasts, podcasts, conferences, and the Bio-IT World Best Practices Awards Program. The magazine is based in Needham, MA.

About Cambridge Healthtech Institute (CHI)
Founded in 1992, Cambridge Healthtech Institute ( is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, academic, and niche service provider organizations. CHI's integrated life science portfolio of products and services includes Cambridge Healthtech Institute Conferences, Pharmaceutical Strategy Series, Barnett International, Cambridge Healthtech Associates, Insight Pharma Reports, Marketing Services, Meeting Planners, and Cambridge Healthtech Media Group, which includes several eNewsletters, Bio-IT World magazine, as well as Lead Generation Programs.

Contact: Kevin Davies (Editor-in-Chief, Bio-IT World): kevin_davies(at)bio-itworld(dot)com, 781-972-1341.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Real Time Genomics to Show SLIM Search(TM) Technology on Windows HPC Server 2008 at Bio-IT World Conference
2. Isilon Hosts Industry Leaders Panel on the Future of Life Sciences and IT at Bio-IT World 2009
3. Keynote Panel at Bio-IT World Expo to Feature Five Leaders in the Field of "Personal Genomics"
4. Genstruct and Sirtris Pharmaceuticals Win Bio-IT Worlds Best Practices Award
5. NC Biomanufacturers Supply Defense for World vs. Flu
6. Thomson Reuters Commemorates World IP Week with Series of Strategic Intellectual Property Seminars Across the U.S.
7. TechConnect World Conference Showcases Houston Leaders May 3-7, at the George R. Brown Convention Center
8. World BioBank(TM) Launch Benefits Advanced Medical Research
9. GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business
10. IVF Baby Born From 21-Year-Old Frozen Sperm, Ties World Record
11. Ansell Healthcare Espresses Firm Commitment to Support Continued Education of Healthcare Professionals Worldwide
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" ... Norman C.W. Wong to its Board of Directors ... to Zenith with a wealth of experience as co-founder of ... biology. --> --> Dr. ... Epigenetics, board of directors. Zenith,s long standing expertise in epigenetics ...
(Date:11/30/2015)... 2015  Champions Oncology, Inc. (CSBR), engaged in the ... the development and use of oncology drugs, today announced ... be presenting at the LD MICRO Investor Conference on ... (PST).  The conference, held at the Luxe Sunset Bel ... , will feature 200 small/micro-cap companies and is expected ...
(Date:11/30/2015)... Nov. 30, 2015  HUYA Bioscience International, the leader ... pharmaceutical innovations, today announced it has signed a ... (KDDF) to foster collaboration between KDDF and HUYA with ... of healthcare products for the global market. ... source of new innovative preclinical and clinical stage compounds. ...
(Date:11/30/2015)... and MAGDEBURG, Germany , November ... NeuroRehabilitation (ECNR) in Vienna, Austria ... European Congress of NeuroRehabilitation (ECNR) in Vienna, ... --> NovaVision, a wholly owned subsidiary of Vycor Medical, ... version of its Internet-delivered NovaVision Therapy Suite at the ...
Breaking Biology Technology:
(Date:11/12/2015)... CAMBRIDGE, Mass. , Nov. 12, 2015 /PRNewswire/ ... Broad Institute of MIT and Harvard for use ... chemical discovery information management tools. The partnership will ... share both biological and chemical research information internally ... tools will be used for managing the Institute,s ...
(Date:11/10/2015)... NEW YORK , Nov. 10, 2015 /PRNewswire/ ... refers to behavioral biometrics that helps to identify ... prevent fraud. Signature is considered as the secure ... for the identification of a particular individual because ... offers more accurate results especially when dynamic signature ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
Breaking Biology News(10 mins):